Integra LifeSciences/IART

$35.99

-3.03%
-
1D1W1MYTD1YMAX

About Integra LifeSciences

Integra LifeSciences Holdings Corporation is a medical technology company. The Company operates through two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS segment consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield and Bactiseal. Its product offering includes CereLink in the Unites States and Europe. The Company’s TT segment focuses on three areas, which include complex wound surgery, surgical reconstruction and peripheral nerve repair. TT's regenerative platform includes multiple brands, such as Integra Dermal Matrices, AmnioExcel, SurgiMend, MicroMatrix and NeuraGen. The Company's manufacturing and research facilities are located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland.

Ticker

IART

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

Stuart Essig

Employees

3,946

Headquarters

Princeton, United States

IART Metrics

BasicAdvanced
$2.89B
Market cap
43.71
P/E ratio
$0.84
EPS
1.13
Beta
-
Dividend rate

What the Analysts think about IART

Analyst Ratings

Majority rating from 14 analysts.
Hold

Price Targets

Average projection from 10 analysts.
24.48% upside
High $57.00
Low $37.00
$35.99
Current price
$44.80
Average price target

IART Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
4.98% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$397M
3.82%
Net income
$19.8M
2.06%
Profit margin
4.98%
-1.78%

IART Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 1.46%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.74
$0.71
$0.76
$0.89
-
Expected
$0.74
$0.57
$0.78
$0.90
$0.58
Surprise
0.43%
24.76%
-2.3%
-1.46%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Integra LifeSciences stock

Buy or sell Integra LifeSciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing